Exercise preconditioning of myocardial infarct size in dogs is triggered by calcium
Artículo
Access note
Acceso abierto
Publication date
2015Metadata
Show full item record
Cómo citar
Parra, Víctor M.
Cómo citar
Exercise preconditioning of myocardial infarct size in dogs is triggered by calcium
Author
Abstract
We showed that exercise induces early and late myocardial preconditioning in dogs and that these effects are mediated through nicotinamide adenine dinucleotide phosphate reduced form (NADPH) oxidase activation. As the intracoronary administration of calcium induces preconditioning and exercise enhances the calcium inflow to the cell, we studied if this effect of exercise triggers exercise preconditioning independently of its hemodynamic effects. We analyzed in 81 dogs the effect of blocking sarcolemmal L-type Ca2+ channels with a low dose of verapamil on early and late preconditioning by exercise, and in other 50 dogs, we studied the effect of verapamil on NADPH oxidase activation in early exercise preconditioning. Exercise reduced myocardial infarct size by 76% and 52% (early and late windows respectively; P < 0.001 both), and these effects were abolished by a single low dose of verapamil given before exercise. This dose of verapamil did not modify the effect of exercise on metabolic and hemodynamic parameters. In addition, verapamil blocked the activation of NADPH oxidase during early preconditioning. The protective effect of exercise preconditioning on myocardial infarct size is triggered, at least in part, by calcium inflow increase to the cell during exercise and, during the early window, is mediated by NADPH oxidase activation.
Patrocinador
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT 1030449
1030446
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDAP 15010006
Appeared in source as:Fondo de Areas Prioritarias (FONDAP), Center for Molecular Studies of the Cell from Chile
Indexation
Artículo de publicación WoS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/166507
DOI: 10.1097/FJC.0000000000000191
ISSN: 15334023
01602446
Quote Item
J Cardiovasc Pharmacol. 2015 Mar;65(3):276-81
Collections